Entellus Medical (ENTL) Misses Q3 EPS by 13c

Entellus Medical (NASDAQ: ENTL) reported Q3 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $17.9 million versus the consensus estimate of $17.93 million.

GUIDANCE:

Entellus Medical sees FY2016 revenue of $74.0-75.5 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c